ERD

Prolonged XPO1 inhibition is essential for optimal anti-leukemic activity in NPM1-mutated AML

Project: ContraNPM1AML

Updated at: 27-04-2024

Show more information

Project acronym ContraNPM1AML

GATA1 epigenetic deregulation contributes to the development of AML with NPM1 and FLT3-ITD cooperating mutations

Project: ContraNPM1AML

Updated at: 27-04-2024

Show more information

Project acronym ContraNPM1AML

Mutant NPM1 Maintains the Leukemic State through HOX Expression

Project: ContraNPM1AML

Updated at: 27-04-2024

Show more information

Project acronym ContraNPM1AML

CD123 Is Consistently Expressed on NPM1-Mutated AML Cells

Project: ContraNPM1AML

Updated at: 27-04-2024

Show more information

Project acronym ContraNPM1AML

Diagnostic and therapeutic pitfalls in NPM1-mutated AML: notes from the field

Project: ContraNPM1AML

Updated at: 27-04-2024

Show more information

Project acronym ContraNPM1AML

ARPIR: automatic RNA-Seq pipelines with interactive report

Project: ContraNPM1AML

Updated at: 27-04-2024

Show more information

Project acronym ContraNPM1AML

Dactinomycin induces complete remission associated with nucleolar stress response in relapsed/refractory NPM1-mutated AM...

Project: ContraNPM1AML

Updated at: 27-04-2024

Show more information

Project acronym ContraNPM1AML

NPM1-mutated acute myeloid leukemia: from bench to bedside

Project: ContraNPM1AML

Updated at: 27-04-2024

Show more information

Project acronym ContraNPM1AML

Periodic Reporting for period 4 - ContraNPM1AML (Dissecting to hit the therapeutic targets in nucleophosmin (NPM1)-mutat...

Project: ContraNPM1AML

Updated at: 27-04-2024

Show more information

Project acronym ContraNPM1AML

Actinomycin D Targets NPM1c-Primed Mitochondria to Restore PML-Driven Senescence in AML Therapy

Project: ContraNPM1AML

Updated at: 27-04-2024

Show more information

Project acronym ContraNPM1AML

A Curious Novel Combination of Nucleophosmin (NPM1) Gene Mutations Leading to Aberrant Cytoplasmic Dislocation of NPM1 i...

Project: ContraNPM1AML

Updated at: 27-04-2024

Show more information

Project acronym ContraNPM1AML

How I diagnose and treat NPM1 -mutated AML

Project: ContraNPM1AML

Updated at: 27-04-2024

Show more information

Project acronym ContraNPM1AML

SiCoDEA: a simple, fast and complete app for analyzing the effect of individual drugs and their combinations.

Project: ContraNPM1AML

Updated at: 27-04-2024

Show more information

Project acronym ContraNPM1AML

NOVEL NPM1 EXON 5 MUTATIONS AND GENE FUSIONS LEADING TO ABERRANT CYTOPLASMIC NUCLEOPHOSMIN IN AML

Project: ContraNPM1AML

Updated at: 27-04-2024

Show more information

Project acronym ContraNPM1AML

Enasidenib and ivosidenib in AML

Project: ContraNPM1AML

Updated at: 27-04-2024

Show more information

Project acronym ContraNPM1AML

Resources

Selected filters:

Prolonged XPO1 inhibition is essential for optimal anti-leukemic activity in NPM1-mutated AML

GATA1 epigenetic deregulation contributes to the development of AML with NPM1 and FLT3-ITD cooperating mutations

Mutant NPM1 Maintains the Leukemic State through HOX Expression

CD123 Is Consistently Expressed on NPM1-Mutated AML Cells

Diagnostic and therapeutic pitfalls in NPM1-mutated AML: notes from the field

ARPIR: automatic RNA-Seq pipelines with interactive report

Dactinomycin induces complete remission associated with nucleolar stress response in relapsed/refractory NPM1-mutated AM...

NPM1-mutated acute myeloid leukemia: from bench to bedside

Periodic Reporting for period 4 - ContraNPM1AML (Dissecting to hit the therapeutic targets in nucleophosmin (NPM1)-mutat...

Actinomycin D Targets NPM1c-Primed Mitochondria to Restore PML-Driven Senescence in AML Therapy

A Curious Novel Combination of Nucleophosmin (NPM1) Gene Mutations Leading to Aberrant Cytoplasmic Dislocation of NPM1 i...

How I diagnose and treat NPM1 -mutated AML

SiCoDEA: a simple, fast and complete app for analyzing the effect of individual drugs and their combinations.

NOVEL NPM1 EXON 5 MUTATIONS AND GENE FUSIONS LEADING TO ABERRANT CYTOPLASMIC NUCLEOPHOSMIN IN AML

Enasidenib and ivosidenib in AML